Table 4.
Summary of Strategies and Recommended Guidelines
| Vaccine | Recommendations/Strategies | Schedules | Comments |
|---|---|---|---|
| Hepatitis B | All new inmates with negative or unknown serology. | Normal: 0, 1 and 6 months Accelerated: 0, 1, 2 and 12 m Rapidly-accelerated: 0, 7, 21 d and 12 m | Previous serology recommended. |
| New inmates with risk factors: IDUs, chronic disease, MSM, mental illness. | |||
| Hepatitis A | All new inmates with negative or unknown serology. | HA: 0 – 6 months HAV/HAVB: 0, 1, 2 and 12m HAV/HBV: 0, 7, 21 and 12 m | Evaluate age and place of origin. |
| New inmates with risk factors: IDUs (pre-serology not necessary), MSM and hepatic risk factors. | |||
| Tetanus/diphtheria | Prisoners without demonstrated history of vaccination. | 0, 1 and 6–12 months (Td) | Evaluate vaccination if there are lesions. |
| All new inmates with last dose > 10 y ago. | 1 booster dose (Td) | ||
| PCV13* and PPSV23** | Prisoners aged more than 65 y* | 0 (PCV13) and 6–12 months (PPSV23). If previous PPSV23, PCV13 > = 1 y* | Two doses of VP23 recommended in specific risk groups** |
| Prisoners aged more than 18 y with baseline pathology included in recommendations** | 0 (PCV13), PPSV23 minimum of 8 weeks later** | ||
| Seasonal influenza | All new inmates | One annual dose during influenza season. | |
| Risk groups: > 65 years, pregnancy, chronic medical condition or immunosuppression | |||
| Mumps, measles and rubella | All new inmates with negative or unknown serology. | History of childhood vaccination: 1 dose. No history of vaccination: 0, 1 month. | |
| Women of child-bearing age. | |||
| Human papilloma virus | Women with no history of vaccination or incomplete vaccination. | 0, 1–2 and 6 months | Prioritize persons aged less than 26 y Upper limits vary by country*** |
| Meningococcal C | Inmates aged less than 26 y | 1 doses | |
| Varicella | Prisoners with proven history of vaccination. | 0–4,8 weeks | |
| Prisoners who remember receiving one dose. | One booster dose |
IDUs: injecting drug users. MSM: Men who have sex with men. HAV: Hepatitis A virus. HBV: Hepatitis B virus. PCV13: 13-valent pneumococcal conjugate vaccine. PPSV23: 23-valent pneumococcal polysaccharide vaccine.
*
CDC 2014 recommendations.102
**
See risk groups: CDC 2012.103
***
WHO 2014: recommends an upper age limit of age of 26 y.122